Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd) (Q39612438)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 20, 2011

Language	Label	Description	Also known as
English	Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd)	scientific article published on January 20, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd) (English)

1 reference

10.1111/J.1349-7006.2010.01837.X

https://api.crossref.org/works/10.1111/J.1349-7006.2010.01837.X

21 November 2024

author name string

Ren Nishio

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Hiroyuki Tsuchiya

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Toshihiro Yasui

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Shizuka Matsuura

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Keita Kanki

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Akihiro Kurimasa

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ichiro Hisatome

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Goshi Shiota

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21205085

21 November 2024

publication date

20 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.2010.01837.x

1 reference

10.1111/J.1349-7006.2010.01837.X

https://api.crossref.org/works/10.1111/J.1349-7006.2010.01837.X

21 November 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1349-7006.2010.01837.x

1 reference

10.1111/J.1349-7006.2010.01837.X

https://api.crossref.org/works/10.1111/J.1349-7006.2010.01837.X

21 November 2024

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

622-629

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Impact of gemcitabine on the treatment of metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Cellular pharmacology of gemcitabine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Synthetic retinoid CD437 induces mitochondria-mediated apoptosis in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Disrupted plasma membrane localization and loss of function reveal regions of human equilibrative nucleoside transporter 1 involved in structural integrity and activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Protein disulfide isomerase: the structure of oxidative folding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Unifying features in protein-folding mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Systematic discovery of new recognition peptides mediating protein interaction networks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01837.X

21 January 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

5

1 reference

10.1111/J.1349-7006.2010.01837.X

https://api.crossref.org/works/10.1111/J.1349-7006.2010.01837.X

21 November 2024

Identifiers

10.1111/J.1349-7006.2010.01837.X

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39612438&oldid=2277852681"